Literature DB >> 27052845

Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.

Tania B Huedo-Medina1,2, Roman Shrestha2,3, Michael Copenhaver4,5.   

Abstract

Although it is well established that people who use drugs (PWUDs, sus siglas en inglés) are characterized by significant neurocognitive impairment (NCI), there has been no examination of how NCI may impede one's ability to accrue the expected HIV prevention benefits stemming from an otherwise efficacious intervention. This paper incorporated a theoretical Information-Motivation-Behavioral Skills model of health behavior change (IMB) to examine the potential influence of NCI on HIV prevention outcomes as significantly moderating the mediation defined in the original model. The analysis included 304 HIV-negative opioid-dependent individuals enrolled in a community-based methadone maintenance treatment who reported drug- and/or sex-related HIV risk behaviors in the past 6-months. Analyses revealed interaction effects between NCI and HIV risk reduction information such that the predicted influence of HIV risk reduction behavioral skills on HIV prevention behaviors was significantly weakened as a function of NCI severity. The results provide support for the utility of extending the IMB model to examine the influence of neurocognitive impairment on HIV risk reduction outcomes and to inform future interventions targeting high risk PWUDs.

Entities:  

Keywords:  Drug users; HIV risk reduction; IMB model; Moderated mediation; Neurocognitive impairment

Mesh:

Year:  2016        PMID: 27052845      PMCID: PMC4945437          DOI: 10.1007/s10461-016-1394-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  59 in total

1.  Dose-related neurobehavioral effects of chronic cocaine use.

Authors:  K I Bolla; R Rothman; J L Cadet
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

2.  Dose-related neurocognitive effects of marijuana use.

Authors:  K I Bolla; K Brown; D Eldreth; K Tate; J L Cadet
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

3.  Empirical tests of an information-motivation-behavioral skills model of AIDS-preventive behavior with gay men and heterosexual university students.

Authors:  J D Fisher; W A Fisher; S S Williams; T E Malloy
Journal:  Health Psychol       Date:  1994-05       Impact factor: 4.267

4.  HIV and risk environment for injecting drug users: the past, present, and future.

Authors:  Steffanie A Strathdee; Timothy B Hallett; Natalia Bobrova; Tim Rhodes; Robert Booth; Reychad Abdool; Catherine A Hankins
Journal:  Lancet       Date:  2010-07-24       Impact factor: 79.321

Review 5.  HIV-1 infection and cognitive impairment in the cART era: a review.

Authors:  Judith Schouten; Paola Cinque; Magnus Gisslen; Peter Reiss; Peter Portegies
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

6.  Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Authors:  Christina S Meade; Nina A Conn; Linda M Skalski; Steven A Safren
Journal:  J Behav Med       Date:  2010-09-21

Review 7.  Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence.

Authors:  Seth M Noar
Journal:  AIDS Behav       Date:  2007-09-21

8.  Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.

Authors:  S Kelly Avants; Arthur Margolin; Mary Helen Usubiaga; Cheryl Doebrick
Journal:  J Subst Abuse Treat       Date:  2004-03

9.  Information-Motivation-Behavioral Skills (IMB) Model: testing direct and mediated treatment effects on condom use among women in low-income housing.

Authors:  Eileen S Anderson; David A Wagstaff; Timothy G Heckman; Richard A Winett; Roger A Roffman; Laura J Solomon; Victoria Cargill; Jeffrey A Kelly; Kathleen J Sikkema
Journal:  Ann Behav Med       Date:  2006-02

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  22 in total

1.  Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Authors:  Roman Shrestha; Frederick L Altice; Brian Sibilio; Jude Ssenyonjo; Michael M Copenhaver
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

2.  Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV.

Authors:  Yue Pan; Lisa R Metsch; Lauren K Gooden; Morgan M Philbin; Eric S Daar; Antoine Douaihy; Petra Jacobs; Carlos Del Rio; Allan E Rodriguez; Daniel J Feaster
Journal:  Int J STD AIDS       Date:  2019-06-03       Impact factor: 1.359

3.  Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Tania B Huedo-Medina; Jaimie P Meyer; Lynn Madden; Michael Copenhaver
Journal:  Drug Alcohol Depend       Date:  2017-02-02       Impact factor: 4.492

4.  A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis.

Authors:  Roman Shrestha; Damian Weikum; Michael Copenhaver; Frederick L Altice
Journal:  Int J Ment Health Addict       Date:  2017-04-03       Impact factor: 3.836

5.  Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Oleksandr Dubov; Liana Fraenkel; Tania Huedo-Medina; Michael Copenhaver
Journal:  AIDS Behav       Date:  2018-04

6.  Interest in use of mHealth technology in HIV prevention and associated factors among high-risk drug users enrolled in methadone maintenance program.

Authors:  Roman Shrestha; Pramila Karki; Michael Copenhaver
Journal:  AIDS Care       Date:  2017-05-08

7.  Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2017-04-19       Impact factor: 1.354

8.  Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).

Authors:  Roman Shrestha; Michael M Copenhaver
Journal:  Addict Behav       Date:  2018-05-31       Impact factor: 3.913

9.  Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2016-09-22       Impact factor: 1.354

10.  The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis.

Authors:  Roman Shrestha; Damian Weikum; Michael Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.